- Active Ingredients
Product Documentation
-
View RMM (RMM- Apixaban Patient Alert Card)
Last updated on this site: 08 Feb 2024
New Patient Alert Card for Apixaban.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintApixaban Accord 2.5mg film-coated tablets
- PL Number:
- PLGB 20075/1405
- MA Holder:
- Accord Healthcare Limited
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Summary of Product Characteristics (SmPC- Apixaban Accord 2.5 mg Film-coated tablets)
Last updated on this site: 18 Oct 2023
Website administration update only- no changes to file.
View Patient Information Leaflet (PIL-Apixaban Accord 2.5 mg film-coated tablets)Last updated on this site: 06 Oct 2023
Description of update: To update sections 4.2 and 5.1 of the SmPC in-line with reference product (Eliquis 2.5 mg/5 mg film coated tablets; procedure number with outcome: EMEA/H/C/002148/II/0088; MAH: Bristol Myers Squibb/Pfizer EEIG, Ireland). Additionally, to update SmPC section 4.2, 4.3, 4.4, 4.6, 4.7, 4.8, 5.1, 5.2 and PIL section 1, 2, 3 and 4 with editorial changes in line with reference product and corrected typo errors in SmPC section 5.1, 5.2 and PIL section 2, 4.
PIL sections updated: 1, 2, 3, 4 and 6.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.